Results 181 to 190 of about 1,428,732 (361)
We retrospectively analyzed clinical data from patients who underwent hepatectomy for hepatocellular carcinoma (HCC) using LCA‐based grading system. These findings provide a new risk stratification framework for the design of precision surgery to treat patients with HCC.
Ling Liu +5 more
wiley +1 more source
Treatment of Chronic Viral Hepatitis with Alpha-Inferon: A Consensus Conference Report
The CASL Hepatitis Consensus Group
doaj +1 more source
ABSTRACT Aim Bile acids accumulation in hepatocytes causes liver damage and contributes to the development of hepatocellular carcinoma. However, the association between serum bile acid levels and postoperative intrahepatic recurrence in hepatocellular carcinoma remains unclear.
Tomoaki Bekki +9 more
wiley +1 more source
Treatment of Chronic Viral Hepatitis with Alpha-Interferon: A Consensus Conference Report
The CASL Hepatitis Consensus Group
doaj +1 more source
Hepatitis-C-virus-induced microRNAs dampen interferon-mediated antiviral signaling
Abigail Jarret +12 more
openalex +1 more source
Benefit‐risk assessment for sofosbuvir/velpatasvir/voxilaprevir based on patient population and hepatitis C virus genotype: U. S. Food and Drug Administration's evaluation [PDF]
Kimberly Struble +4 more
openalex +1 more source
ABSTRACT The therapeutic landscape of hepatocellular carcinoma (HCC) has been transformed by recent advancements in systemic therapies, particularly with the introduction of immune checkpoint inhibitors, expanding treatment options beyond conventional locoregional approaches.
Keiichi Akahoshi +4 more
wiley +1 more source
P67 Strategies supporting and increasing hepatitis C testing and treatment for people in NSW prisons
S. Wilkinson, M. McMahon
doaj +1 more source
Immunogenicity and Antiviral Response of Therapeutic Hepatitis B Vaccination in a Mouse Model of HBeAg-Negative, Persistent HBV Infection [PDF]
Anna D. Kosinska +5 more
openalex +1 more source

